An interventional study of Mindfulness and Control in Patient Satisfaction, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Completed at 1 site in Spain. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-03-16.
Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Not applicable, Interventional, and Supportive care
Randomized, multicenter, international clinical trial (one center in Barcelona and one center in Bergamo, Italy), with exploratory intention.
The main objective of the study will be to assess changes in quality of life, mood, chronic pain and sleep after the delivery of a Mindfulness program.
The secondary objectives will be: to evaluate if this program also affects blood pressure, if the changes are maintained six months after treatment and if it determines the decrease in health resources used.
The intervention group will do Mindfulness sessions according to an established protocol of 8 weeks, while the control group will follow the normal clinical routine. The Mindfulness protocol will be carried out in group sessions led by a therapist with experience in mindfulness and compassion, lasting 120 minutes, weekly, which will take place over 8 weeks.
Two separate studies will be done, one for patients with acromegaly which will be the first to take place and then another for patients with Cushing's syndrome.
Sixty patients with acromegaly, (30 in Spain and 30 in Italy) and 60 patients with Cushing syndrome (30 in Spain and 30 in Italy), who are visited in the Endocrinology services of the Hospital de la Santa Creu i Sant Pau, Barcelona and Papa Giovanni XXIII in Bergamo will participate in the study.
In each center there will be 30 patients for each pathology (15 will participate in the Mindfulness intervention group and 15 will receive the usual treatment).
Inclusion criteria: 1) age between 18 and 70 years, 2) diagnosis of acromegaly, 3) diagnosis of Cushing's syndrome, 4) patients with controlled disease, 5) not currently participating in any other clinical study.
Exclusion criteria: 1) physical illnesses or comorbidity of serious mental illness that impede the practice of Mindfulness, 2) Patients who for cognitive, neurological or psychiatric reasons could not follow the sessions 3) Patients who do not accept signing the informed consent 4) Patients with Cushing's syndrome or active acromegaly, 5) Simultaneous participation in another clinical study.
Patients who meet the inclusion / exclusion criteria will be invited to participate in the study. The Patient Information Sheet (HIP) and Informed Consent (CI) will be provided. There will be three evaluation visits (pre and post intervention, and 6 months after the intervention) in which the participants must complete different questionnaires and scales. Participants will be invited to keep a daily practice log, and will be required to complete the assigned daily meditation practices for the 8-week program.
Demographic and clinical variables (collected from the medical history) will be included. Patients will also have their blood pressure taken before and after each session.
Questionnaires:
196 studies on the registry are indexed under Acromegaly; 18 are open to participants now.
This study's enrollment of 60 is above the median of 43 across 115 interventional studies indexed under Acromegaly.
Browse Acromegaly studies →Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is the lead sponsor of 335 studies on the registry; 64 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients having a Mindfulness program
Behavioral: Mindfulness
Patients having a routinary managment
Other: Control
Mindfulness based programme
Treatment as usual
Change in quality of life in patients with acromegaly
using the Acromegaly Quality of Life Questionnaire (AcroQoL)
Time frame: Baseline, post-intervention (8 weeks)
Change in quality of life in patients with Cushing's syndrome
using the Cushing's Quality-of-Life (CushingQOL) questionnaire
Time frame: Baseline, post-intervention (8 weeks)
Change in Pain in patients with acromegaly and Cushing's syndrome
as evaluated using the McGill Pain Questionnaire
Time frame: Baseline, post-intervention (8 weeks)
Change in Mood in patients with acromegaly and Cushing's syndrome
as evaluate using Hospital Anxiety and Depression Scale (HADS)
Time frame: Baseline, post-intervention (8 weeks)
Change in Sleep in patients with acromegaly and Cushing's syndrome
as evaluate using Pittsburgh sleep scale
Time frame: Baseline, post-intervention (8 weeks)
Self compassion in patients with acromegaly and Cushing's syndrome
as evaluate using Self Compassion Scale (SCS)
Time frame: Baseline, post-intervention (8 weeks)
Satisfation with life in patients with acromegaly and Cushing's syndrome
as evaluate using SWLS questionnaire
Time frame: Baseline, post-intervention (8 weeks)
Plan to share: No — We'll publish the data after completing the study
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau